levonorgestrel has been researched along with Thrombosis in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (21.05) | 18.7374 |
| 1990's | 4 (21.05) | 18.2507 |
| 2000's | 5 (26.32) | 29.6817 |
| 2010's | 3 (15.79) | 24.3611 |
| 2020's | 3 (15.79) | 2.80 |
| Authors | Studies |
|---|---|
| Wunder, D | 1 |
| Alvarez-Villalobos, NA; Burciaga-Jimenez, E; Diaz Gonzalez-Colmenero, F; Flores-Rodriguez, A; Garcia-Leal, M; Morales-Martinez, FA; Rodríguez-Guajardo, R; Rodriguez-Gutierrez, R; Saenz-Flores, M; Sordia-Hernandez, LH; Zuñiga-Hernandez, JA | 1 |
| Bahamondes, L; Brull, EP; Fernandes, A; Juliato, CRT; Monteiro, I | 1 |
| Boesch, C; Bronner, C; Hecker, M; Jourdain, M; Schini-Kerth, VB; Zerr-Fouineau, M | 1 |
| Aiach, M; Alhenc-Gelas, M; Ali, FD; Bachelot-Loza, C; Gaussem, P; Remones, V; Scarabin, PY; Thomas, JL | 1 |
| Burggraaf, J; Cohen, AF; de Kam, ML; Kluft, C; Rad, M | 1 |
| Ishak, R | 1 |
| Ahmad, R; Ang, ES; Gudum, HR; Hassan, K; Ishak, R | 1 |
| Andersen, LF; Bladbjerg, EM; Jespersen, J; Skouby, SO | 1 |
| Algra, A; Bouma, BN; Curvers, J; Grobbee, DE; Kemmeren, JM; Meijers, JC; Rosing, J; Tans, G | 1 |
| Cuadrado, MJ; Hunt, BJ; Khamashta, MA; Pisoni, CN | 1 |
| Wingrave, SJ | 1 |
| Algra, A; Bollen, EL; Helmerhorst, FM; Kemmeren, JM; Rosendaal, FR; Tanis, BC; van den Bosch, MA; van der Graaf, Y | 1 |
| Ratnam, SS; Singh, K; Viegas, OA | 1 |
| Koh, S; Ratnam, SS; Singh, K; Singh, P; Viegas, OA | 2 |
| Bonnar, J | 1 |
1 review(s) available for levonorgestrel and Thrombosis
| Article | Year |
|---|---|
Harms of third- and fourth-generation combined oral contraceptives in premenopausal women: A systematic review and meta-analysis.
Topics: Cholesterol; Contraceptives, Oral, Combined; Female; Humans; Incidence; Levonorgestrel; Thrombosis | 2023 |
4 trial(s) available for levonorgestrel and Thrombosis
| Article | Year |
|---|---|
Haemostatic effects of a new combined oral contraceptive, nomegestrol acetate/17β-estradiol, compared with those of levonorgestrel/ethinyl estradiol. A double-blind, randomised study.
Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Double-Blind Method; Estradiol; Ethinyl Estradiol; Female; Fibrinolysis; Hemostasis; Humans; Levonorgestrel; Megestrol; Norpregnadienes; Placebos; Thrombosis; Treatment Outcome | 2011 |
Effects of different progestin regimens in hormone replacement therapy on blood coagulation factor VII and tissue factor pathway inhibitor.
Topics: Cholesterol, LDL; Cyproterone Acetate; Estradiol; Estrogen Replacement Therapy; Factor VII; Female; Humans; Levonorgestrel; Lipoproteins; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Norethindrone Acetate; Placebos; Postmenopause; Progestins; Risk Factors; Thrombosis; Time Factors; Uterus | 2002 |
Effect of second- and third-generation oral contraceptives on the protein C system in the absence or presence of the factor VLeiden mutation: a randomized trial.
Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Factor V; Female; Humans; Levonorgestrel; Mutation; Protein C; Risk Factors; Thrombosis | 2004 |
Progestogen effects and their relationship to lipoprotein changes. A report from the Oral Contraception Study of the Royal College of General Practitioners.
Topics: Breast Neoplasms; Clinical Trials as Topic; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Ethinyl Estradiol; Female; Humans; Hypertension; Levonorgestrel; Lipoproteins; Mestranol; Norethindrone; Norethindrone Acetate; Norgestrel; Progestins; Prospective Studies; Thrombosis | 1982 |
14 other study(ies) available for levonorgestrel and Thrombosis
| Article | Year |
|---|---|
[The Thromboembolism Risk with Combined Hormonal Contraceptives: Current Status and Prescribing Practice].
Topics: Contraceptive Agents; Female; Humans; Levonorgestrel; Risk Factors; Thrombosis; Venous Thromboembolism | 2023 |
Safety and bleeding patterns of the levonorgestrel 52-mg intrauterine system among women with thrombosis or coagulopathy.
Topics: Adult; Amenorrhea; Anticoagulants; Blood Coagulation Disorders; Brazil; Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Oligomenorrhea; Retrospective Studies; Thromboembolism; Thrombosis | 2020 |
Drospirenone: more cases of thrombosis than with levonorgestrel.
Topics: Adolescent; Adult; Androstenes; Child; Contraceptive Agents, Female; Female; Humans; Levonorgestrel; Middle Aged; Thrombosis | 2013 |
Certain progestins prevent the enhancing effect of 17beta-estradiol on NO-mediated inhibition of platelet aggregation by endothelial cells.
Topics: Blood Platelets; Cells, Cultured; Dose-Response Relationship, Drug; Endothelial Cells; Estradiol; GTP Cyclohydrolase; Hormone Antagonists; Humans; Levonorgestrel; Medroxyprogesterone Acetate; Megestrol; Mifepristone; Nitric Oxide; Nitric Oxide Synthase Type III; Norpregnadienes; Platelet Aggregation; Progesterone; Progesterone Congeners; Pterins; Receptors, Glucocorticoid; Receptors, Progesterone; RNA, Messenger; Thrombosis; Time Factors | 2009 |
Discriminant analysis of the metabolic effects of a new combined contraceptive vaginal ring containing Nestorone/EE vs. a second-generation oral contraceptive containing levonorgestrel/EE.
Topics: Angiotensinogen; Blood Coagulation Factors; Blood Pressure; C-Reactive Protein; Cholesterol, HDL; Cholesterol, LDL; Contraceptive Devices, Female; Contraceptives, Oral, Combined; Discriminant Analysis; Drug Combinations; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norprogesterones; Risk; Sex Hormone-Binding Globulin; Thrombosis; Triglycerides | 2012 |
Effect of combined low-dose oral contraceptives on blood viscosity and haematocrit.
Topics: Asia; Asia, Southeastern; Biology; Blood; Blood Coagulation; Case-Control Studies; Clinical Laboratory Techniques; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Cross-Sectional Studies; Desogestrel; Developing Countries; Diagnosis; Disease; Embolism; Ethinyl Estradiol; Family Planning Services; Hematocrit; Hematologic Tests; Levonorgestrel; Malaysia; Methods; Physiology; Research; Research Design; Thromboembolism; Thrombosis; Vascular Diseases | 1991 |
Pill research results in new guidance from CSM.
Topics: Biology; Communication; Consumer Product Safety; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Delivery of Health Care; Demography; Desogestrel; Developed Countries; Disease; Embolism; Europe; Evaluation Studies as Topic; Family Planning Services; Geography; Health; Health Personnel; Knowledge; Levonorgestrel; Norethindrone; Population; Public Health; Residence Characteristics; Risk Assessment; Risk Factors; Safety; Thromboembolism; Thrombosis; United Kingdom; Vascular Diseases | 1995 |
Fibrinolytic response in women on low-dose oral contraceptive.
Topics: Asia; Asia, Southeastern; Biology; Blood; Blood Coagulation; Clinical Laboratory Techniques; Clinical Trials as Topic; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Developing Countries; Diagnosis; Disease; Embolism; Family Planning Services; Fibrinolysis; Hematologic Tests; Levonorgestrel; Malaysia; Physiology; Research; Thromboembolism; Thrombosis; Vascular Diseases | 1992 |
Treatment of menorrhagia associated with oral anticoagulation: efficacy and safety of the levonorgestrel releasing intrauterine device (Mirena coil).
Topics: Administration, Oral; Adult; Anticoagulants; Contraceptive Agents, Female; Female; Humans; Intrauterine Devices; Levonorgestrel; Menorrhagia; Middle Aged; Patient Satisfaction; Surveys and Questionnaires; Thrombosis; Treatment Outcome; Warfarin | 2006 |
Risk of Arterial Thrombosis in Relation to Oral Contraceptives (RATIO) study: oral contraceptives and the risk of ischemic stroke.
Topics: Adolescent; Adult; Arterial Occlusive Diseases; Brain Ischemia; Case-Control Studies; Comorbidity; Contraceptives, Oral; Desogestrel; Dose-Response Relationship, Drug; Female; Humans; Levonorgestrel; Middle Aged; Netherlands; Norpregnenes; Odds Ratio; Risk Assessment; Risk Factors; Stroke; Surveys and Questionnaires; Thrombosis | 2002 |
A three-year evaluation of hemostatic function in Singaporean Norplant acceptors.
Topics: Blood Coagulation Factors; Blood Platelets; Contraceptive Agents, Female; Drug Implants; Female; Fibrinolysis; Hemostasis; Humans; Levonorgestrel; Longitudinal Studies; Norgestrel; Thrombosis | 1990 |
Two-year follow-up of changes in clinical chemistry in Singaporean Norplant acceptors: haemostatic changes.
Topics: Blood Coagulation; Female; Humans; Levonorgestrel; Longitudinal Studies; Norgestrel; Platelet Aggregation; Platelet Count; Singapore; Thrombosis | 1989 |
Two-year follow-up of changes in clinical chemistry in Singaporean Norplant-2 rod acceptors: haemostatic changes.
Topics: Blood Coagulation; Female; Fibrinogen; Humans; Levonorgestrel; Longitudinal Studies; Norgestrel; Platelet Aggregation; Platelet Count; Singapore; Thrombosis | 1989 |
Coagulation effects of oral contraception.
Topics: Blood Coagulation; Contraceptives, Oral; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Fibrinogen; Fibrinolysis; Humans; Levonorgestrel; Mestranol; Norethindrone; Norethindrone Acetate; Norgestrel; Norpregnenes; Platelet Aggregation; Risk Factors; Thromboembolism; Thrombosis | 1987 |